MarketPeel
Insider Trading Intelligence
GS

Gaurav Shah

RCKT
CEO · ROCKET PHARMACEUTICALS, INC. · CIK 0001725922
FILING MIX · LIFETIME38%/62%
BUYS
28
SELLS
45
TOTAL VALUE
$12.63M
COMPANIES
1
ACTIVE SINCE
Feb 2020
HOLDINGS NOW
1,117,408
AVG SELL PX
$23.45
TRADE KIND
SHOWING 73 / 73
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
15 backtested trades · 8 horizons · 14 pending
Forward-return performance of every backtestable P/S trade by Gaurav Shah, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d15+66.67%-0.12%-0.07%-0.06%+0.90%
14d15+53.33%+1.30%+0.55%+0.75%-0.94%
30d15+53.33%+0.22%+0.59%-0.37%-4.65%
60d15+60.00%-13.98%+3.28%-17.26%-18.58%
90d15+60.00%-18.09%+5.16%-23.25%-28.20%
180d15(2 pending)+69.23%-23.43%+10.00%-33.43%-46.94%
1y15(3 pending)+66.67%-32.30%+19.84%-52.15%-75.70%
2y15(9 pending)+100.00%-50.87%+41.28%-92.14%-122.21%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
RCKT · 1,117,408 shares · as of May 21, 2026
0279,352558,704838,0561,117,408202120222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2020
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 28 buys / 45 sellsCOVERAGE · 26 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
RCKT
ROCKET PHARMACEUTICALS, INC.
SALE
CEO
76,490$1.69$129.3K0May 21, 2026May 26, 2026View →
RCKT
ROCKET PHARMACEUTICALS, INC.
SALE
CEO
55,684$3.09$171.8K1,061,724May 21, 2026May 26, 2026View →
RCKT
ROCKET PHARMACEUTICALS, INC.
PURCHASE
CEO
76,490$1.69$129.3K1,117,408May 21, 2026May 26, 2026View →
RCKT
ROCKET PHARMACEUTICALS, INC.
SALE
CEO
2,409$3.01$7.3K1,040,918May 19, 2026May 21, 2026View →
RCKT
ROCKET PHARMACEUTICALS, INC.
SALE
CEO
2,728$3.61$9.8K1,043,327May 13, 2026May 14, 2026View →
RCKT
ROCKET PHARMACEUTICALS, INC.
SALE
CEO
5,990$3.34$20.0K1,046,055Feb 18, 2026Feb 20, 2026View →
RCKT
ROCKET PHARMACEUTICALS, INC.
SALE
CEO
12,279$3.31$40.7K1,052,045Feb 13, 2026Feb 18, 2026View →
RCKT
ROCKET PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
286,0281,064,324Feb 11, 2026Feb 13, 2026View →
RCKT
ROCKET PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
870,648870,648Feb 11, 2026Feb 13, 2026View →
RCKT
ROCKET PHARMACEUTICALS, INC.
SALE
CEO
6,276$2.98$18.7K778,296Nov 18, 2025Nov 20, 2025View →
RCKT
ROCKET PHARMACEUTICALS, INC.
SALE
CEO
2,234$3.05$6.8K784,572Aug 18, 2025Aug 20, 2025View →
RCKT
ROCKET PHARMACEUTICALS, INC.
SALE
CEO
2,253$6.45$14.5K786,806May 20, 2025May 22, 2025View →
RCKT
ROCKET PHARMACEUTICALS, INC.
SALE
CEO
3,621$6.53$23.6K789,059May 16, 2025May 20, 2025View →
RCKT
ROCKET PHARMACEUTICALS, INC.
PURCHASE
CEO
20,000$5.08$101.6K792,680Apr 10, 2025Apr 14, 2025View →
RCKT
ROCKET PHARMACEUTICALS, INC.
SALE
CEO
16,303$10.58$172.5K772,680Feb 21, 2025Feb 25, 2025View →
RCKT
ROCKET PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
243,345243,345Feb 11, 2025Feb 13, 2025View →
RCKT
ROCKET PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
81,655788,983Feb 11, 2025Feb 13, 2025View →
RCKT
ROCKET PHARMACEUTICALS, INC.
SALE
CEO
11,091$13.05$144.8K707,328Nov 21, 2024Nov 25, 2024View →
RCKT
ROCKET PHARMACEUTICALS, INC.
SALE
CEO
9,650$18.50$178.6K718,419Aug 16, 2024Aug 20, 2024View →
RCKT
ROCKET PHARMACEUTICALS, INC.
SALE
CEO
9,790$23.35$228.6K728,069May 16, 2024May 20, 2024View →
RCKT
ROCKET PHARMACEUTICALS, INC.
SALE
CEO
7,97923,940May 14, 2024May 20, 2024View →
RCKT
ROCKET PHARMACEUTICALS, INC.
SALE
CEO
9,68367,785May 14, 2024May 20, 2024View →
RCKT
ROCKET PHARMACEUTICALS, INC.
PURCHASE
CEO
9,683646,134May 14, 2024May 20, 2024View →
RCKT
ROCKET PHARMACEUTICALS, INC.
PURCHASE
CEO
7,979636,451May 14, 2024May 20, 2024View →
RCKT
ROCKET PHARMACEUTICALS, INC.
SALE
CEO
20,272$29.84$604.9K554,762Feb 16, 2024Feb 21, 2024View →
RCKT
ROCKET PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
66,577621,339Feb 16, 2024Feb 21, 2024View →
RCKT
ROCKET PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
196,336196,336Feb 16, 2024Feb 21, 2024View →
RCKT
ROCKET PHARMACEUTICALS, INC.
SALE
CEO
46,828575,034Feb 14, 2024Feb 16, 2024View →
RCKT
ROCKET PHARMACEUTICALS, INC.
SALE
CEO
38,84977,468Feb 14, 2024Feb 16, 2024View →
RCKT
ROCKET PHARMACEUTICALS, INC.
SALE
CEO
7,97931,919Feb 14, 2024Feb 16, 2024View →
RCKT
ROCKET PHARMACEUTICALS, INC.
SALE
CEO
7,979532,833Nov 14, 2023Nov 16, 2023View →
RCKT
ROCKET PHARMACEUTICALS, INC.
SALE
CEO
7,97939,898Nov 14, 2023Nov 16, 2023View →
RCKT
ROCKET PHARMACEUTICALS, INC.
SALE
CEO
4,767$15.47$73.8K524,854Aug 17, 2023Aug 21, 2023View →
RCKT
ROCKET PHARMACEUTICALS, INC.
SALE
CEO
7,97947,877Aug 14, 2023Aug 15, 2023View →
RCKT
ROCKET PHARMACEUTICALS, INC.
PURCHASE
CEO
7,979529,621Aug 14, 2023Aug 15, 2023View →
RCKT
ROCKET PHARMACEUTICALS, INC.
SALE
CEO
4,122$21.38$88.1K521,642May 17, 2023May 19, 2023View →
RCKT
ROCKET PHARMACEUTICALS, INC.
SALE
CEO
7,97955,856May 14, 2023May 16, 2023View →
RCKT
ROCKET PHARMACEUTICALS, INC.
PURCHASE
CEO
7,979525,764May 14, 2023May 16, 2023View →
RCKT
ROCKET PHARMACEUTICALS, INC.
SALE
CEO
12,194$19.06$232.4K536,885Feb 17, 2023Feb 22, 2023View →
RCKT
ROCKET PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
116,317116,317Feb 14, 2023Feb 22, 2023View →
RCKT
ROCKET PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
348,590348,590Feb 14, 2023Feb 22, 2023View →
RCKT
ROCKET PHARMACEUTICALS, INC.
SALE
CEO
67,7850Feb 14, 2023May 20, 2024View →
RCKT
ROCKET PHARMACEUTICALS, INC.
PURCHASE
CEO
67,785737,859Feb 14, 2023May 20, 2024View →
RCKT
ROCKET PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
116,317116,317Feb 14, 2023Feb 16, 2023View →
RCKT
ROCKET PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
348,590348,590Feb 14, 2023Feb 16, 2023View →
RCKT
ROCKET PHARMACEUTICALS, INC.
PURCHASE
CEO
31,44063,835Feb 14, 2023Feb 22, 2023View →
RCKT
ROCKET PHARMACEUTICALS, INC.
PURCHASE
CEO
31,440549,079Feb 14, 2023Feb 22, 2023View →
RCKT
ROCKET PHARMACEUTICALS, INC.
SALE
CEO
23,9400Feb 14, 2022May 20, 2024View →
RCKT
ROCKET PHARMACEUTICALS, INC.
PURCHASE
CEO
23,940670,074Feb 14, 2022May 20, 2024View →
RCKT
ROCKET PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
297,037297,037Feb 14, 2022Feb 16, 2022View →
RCKT
ROCKET PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
95,27595,275Feb 14, 2022Feb 16, 2022View →
RCKT
ROCKET PHARMACEUTICALS, INC.
PURCHASE
CEO
22,000$17.34$381.5K517,639Feb 7, 2022Feb 8, 2022View →
RCKT
ROCKET PHARMACEUTICALS, INC.
SALE
CEO
5,919$45.21$267.6K511,986Apr 1, 2021Apr 1, 2021View →
RCKT
ROCKET PHARMACEUTICALS, INC.
SALE
CEO
8,872$46.45$412.1K503,114Apr 1, 2021Apr 1, 2021View →
RCKT
ROCKET PHARMACEUTICALS, INC.
SALE
CEO
7,475$47.21$352.9K495,639Apr 1, 2021Apr 1, 2021View →
RCKT
ROCKET PHARMACEUTICALS, INC.
SALE
CEO
75,8800Mar 31, 2021Apr 1, 2021View →
RCKT
ROCKET PHARMACEUTICALS, INC.
SALE
CEO
61,350$44.24$2.71M548,401Mar 31, 2021Apr 1, 2021View →
RCKT
ROCKET PHARMACEUTICALS, INC.
SALE
CEO
3,000$45.59$136.8K609,751Mar 31, 2021Apr 1, 2021View →
RCKT
ROCKET PHARMACEUTICALS, INC.
SALE
CEO
23,003$45.06$1.04M525,398Mar 31, 2021Apr 1, 2021View →
RCKT
ROCKET PHARMACEUTICALS, INC.
PURCHASE
CEO
75,880$1.69$128.2K612,751Mar 31, 2021Apr 1, 2021View →
RCKT
ROCKET PHARMACEUTICALS, INC.
SALE
CEO
7,493$45.94$344.2K517,905Mar 31, 2021Apr 1, 2021View →
RCKT
ROCKET PHARMACEUTICALS, INC.
SALE
CEO
19,984$41.80$835.3K614,092Mar 30, 2021Apr 1, 2021View →
RCKT
ROCKET PHARMACEUTICALS, INC.
SALE
CEO
48,732$43.86$2.14M545,376Mar 30, 2021Apr 1, 2021View →
RCKT
ROCKET PHARMACEUTICALS, INC.
SALE
CEO
8,667$42.80$370.9K594,108Mar 30, 2021Apr 1, 2021View →
RCKT
ROCKET PHARMACEUTICALS, INC.
SALE
CEO
8,505$44.34$377.1K536,871Mar 30, 2021Apr 1, 2021View →
RCKT
ROCKET PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
185,000185,000Feb 4, 2021Feb 8, 2021View →
RCKT
ROCKET PHARMACEUTICALS, INC.
SALE
President & CEO
90,9250Mar 24, 2020Mar 26, 2020View →
RCKT
ROCKET PHARMACEUTICALS, INC.
PURCHASE
President & CEO
90,925$0.43$39.1K1,061,642Mar 24, 2020Mar 26, 2020View →
RCKT
ROCKET PHARMACEUTICALS, INC.
SALE
President & CEO
32,645$13.78$449.8K1,028,997Mar 24, 2020Mar 26, 2020View →
RCKT
ROCKET PHARMACEUTICALS, INC.
SALE
President & CEO
290,00090,925Feb 25, 2020Feb 27, 2020View →
RCKT
ROCKET PHARMACEUTICALS, INC.
PURCHASE
President & CEO
290,000$0.43$125.6K976,950Feb 25, 2020Feb 27, 2020View →
RCKT
ROCKET PHARMACEUTICALS, INC.
SALE
President & CEO
6,233$20.15$125.6K970,717Feb 25, 2020Feb 27, 2020View →
RCKT
ROCKET PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
383,306383,306Feb 6, 2020Feb 10, 2020View →
Other insiders · RCKT
Loading peer insiders…
About this filer
CIK 0001725922
ROLE
CEO
PRIMARY
RCKT
COMPANIES
1
ACTIVE SINCE
Feb 2020
MARKETPEEL · /INSIDER/0001725922DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback